Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway: a Pilot Before and After Study

NCT04070053 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT04070053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04070053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway: a Pilot Before and After Study
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2019
Completion date
March 30, 2022
Enrollment
920 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, ards, human, hypoxemic respiratory failure